|
|
Aleksandra Sikora, PhD. Associate Professor of Pharmacoproteomics in the College of Pharmacy at Oregon State University (Corvallis, Oregon, USA) is a microbiologist with experience in bacterial pathogenesis, proteomics, and high-throughput screening for identification of new antimicrobials. She currently focuses on proteomics-driven antigen mining to develop gonorrhea vaccine(s) as well as identification of new antibiotics targeting drug-resistant bacterial infections.
Dr. Sikora received her Masters degree in the field of Microbiology from University of Gdansk (Gdansk, Poland) and PhD in Molecular Biology from University of Gdansk, followed by five years of postdoctoral training in the Department of Microbiology and Immunology at the University of Michigan Medical School (Ann Arbor, Michigan, USA). She started her independent position as an Assistant Professor at OSU in August of 2011 where she has built an extramurally funded research program. Dr. Sikora’s research team utilizes proteomics technology (iTRAQ) to identify novel Neisseria gonorrhoeae vaccine candidates and virulence factors. High-throughput screening of small molecule inhibitors that target central players in bacterial physiology such as the type II secretion pathway and Obg protein are a second focus of her laboratory.
Dr. Sikora has nearly thirty publications including primary research reports, reviews and book chapters. She is a recipient of several prestigious awards including Women’s Career Development Grant from American Society for Microbiology (2010), OSU President’s Commission on the Status of Women Scholarship (2014), and was recently awarded Phi Kappa Phi Emerging Scholar Award (2016).
|